Funding Opportunities: 

Defence

This funding opportunity provides loans of £100,000 to £5 million for late-stage R&D projects by UK-registered SMEs that must start by 1 January 2026. It targets highly innovative projects with clear commercialisation routes and significant economic impact, especially in future economy areas highlighted by Innovate UK. Applicants must show a need for public funding, the ability to repay loans, and a credible repayment plan. Eligible projects should deliver new or significantly improved products, processes, or services and fall within key areas such as Net Zero (energy, industrial processes, agriculture, food, capital intensity), Health and Wellbeing (ill health, wellbeing, diet, food), and Next Generation Digital and Technology Families (AI, advanced computing, bioinformatics, genomics, robotics, smart machines, advanced materials, quantum, energy and environment technologies). Funding is awarded competitively across multiple rounds, with project durations of up to five years covering both R&D and commercialisation phases.

This competition aims to strengthen collaborative research and development between the Netherlands and the UK to commercialise quantum technologies. It funds feasibility and industrial research projects focused on developing, prototyping, and testing commercial quantum solutions in areas such as entanglement-based quantum networking, quantum computing algorithms and software, and quantum sensing for applications like biosensing, public infrastructure, and positioning, navigation, and timing (PNT).

​The EIC Accelerator Challenges 2025 offer €250 million to support startups and SMEs developing breakthrough technologies in five key areas: advanced materials, low-emission food production, generative AI, in-space services, and future mobility. Each challenge has a dedicated budget of €50 million. These initiatives aim to drive innovation and address significant EU objectives. ​

The Future Leaders Fellowships: Round 10 competition, administered by UK Research and Innovation (UKRI), aims to support ambitious research and innovation projects across various sectors. It seeks to foster excellence in innovation, encourage interdisciplinary collaboration, and develop the next generation of research and innovation leaders.

This competition offers up to £7.8 million to support collaborative R&D projects (£1m–£3m eligible costs) that improve productivity, sustainability, and resilience in English agriculture, accelerate the transition to net zero, and deliver clear commercial benefits to farmers, growers, or foresters. Projects must be collaborative, include at least one SME, involve end users and the UK research community, last up to 30 months, and demonstrate strong knowledge exchange plans to drive sector-wide adoption.

This competition funds feasibility studies that explore new solutions to major on-farm or post-farmgate challenges, aiming to improve productivity, resilience, and sustainability while moving towards low-emission farming. It supports early-stage projects that could significantly enhance the efficiency and environmental performance of UK agriculture, focusing on practical benefits for farmers, growers, and foresters. The goal is to accelerate research and development by encouraging collaboration with the wider UK research community. Projects should align with one or more key themes: farmed animals, plants, novel food production systems, or the bioeconomy and agroforestry.

PACE funds innovative, high-risk, early-stage drug discovery and diagnostic projects aimed at developing new therapeutics for bacterial infections with high unmet need. It supports Hit-to-Lead and Lead Optimisation projects targeting Gram-negative bacteria, especially those causing respiratory, bloodstream, and urinary tract infections, including priority pathogens such as A. baumannii, E. coli, K. pneumoniae, P. aeruginosa, and P. mirabilis. Eligible applicants include academic researchers and SMEs worldwide, with projects lasting up to two years. Late-stage, clinical, or vaccine-focused projects, as well as those not directly developing antimicrobials, are out of scope.

The AMALTEA Project, funded under the EU's Horizon Europe programme, aims to revolutionize the construction sector by integrating Artificial Intelligence (AI), robotics, and digitalization into the design, manufacturing, installation, and disassembly of modular facades. The project seeks to enhance sustainability, efficiency, and safety in construction processes, aligning with the European Green Deal objectives.

This programme supports early-stage deep-tech startups in widening countries to develop their technology, business, and investment readiness from TRL 4 to TRL 6. It offers individual grants of €300,000–€500,000, along with coaching, mentoring, and networking for up to two years. Eligible applicants are SMEs or small mid-caps from Horizon Europe widening countries with high-impact innovations, proven intellectual property rights, clear market pathways with measurable goals, and strong ambition to scale. Eligible countries include Bulgaria, Croatia, Cyprus, Czechia, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Portugal, Romania, Slovakia, Slovenia, and associated or equivalent countries such as Albania, Armenia, Bosnia & Herzegovina, Faroe Islands, Georgia, Kosovo, Moldova, Montenegro, North Macedonia, Serbia, Tunisia, Türkiye, Ukraine, Morocco (once associated), and the EU Outermost Regions.

‍

The aim of the Scale up Fund is to support manufacturing facility and process development at pilot scale or demonstration scale. These projects will enable businesses to validate manufacturing capability and commercial viability, achieving market entry at the targeted production volume from the project outcomes.

This competition funds feasibility studies developing new solutions to on-farm or post-farmgate challenges that improve productivity, resilience, and sustainability in UK agriculture. Projects should support low-emission farming and deliver commercial benefits for farmers, growers, and foresters, focusing on areas such as farmed animals, plants, novel food systems, and the bioeconomy or agroforestry. Funding excludes equine, fisheries, aquaculture, and medicinal crop projects. Eligible applicants are established UK businesses collaborating with at least one other organisation, such as another business, research body, or charity.

‍

You can apply for funding from ESA for the Open Call for Proposals or through specific themed opportunities. Your project must delivered R&D related to the space industry

​The European Space Agency's Open Call for Proposals invites businesses from any sector to apply for funding throughout the year to develop new commercial services that utilise one or more space assets, such as satellite communications, Earth observation, or satellite navigation.

This is a multi-sector generous loan opportunity of between £100k and £2m for UK registered, highly innovative SMEs with projects lasting up to 5 years.

Creative UK have partnered with Triodos Bank on the Creative Growth Finance fund to offer loans of £100,000 to £1m* to businesses that bring change, disruption and new IP to the creative industries, harness creativity with technologies and supporting businesses and are talent led.

The SMART: SCOTLAND grant aims to support high-risk, highly ambitious projects providing support to conduct feasibility studies. It’s only available to small and medium enterprises (SMEs) based in Scotland

NIHR i4i Challenge Awards support the real-world evaluation of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for us in the NHS or social care system. The i4i Challenge Awards provide funding for collaborative projects with a focus on implementation research on technologies which have demonstrated safety and efficacy, and have a clear pathway towards adoption and commercialisation.

‍

Arts Council National Lottery are offering funding to people in England who are creative, or work in the arts, museums or libraries. The fund supports thousands of individual practitioners, community and cultural organisations

This funding opportunity supports collaborative arts and humanities research projects, enabling researchers to establish or enhance interdisciplinary and international partnerships, foster early-career researcher development, and maximise the impact of research outcomes through effective communication and knowledge transfer. Proposals should prioritize arts and humanities perspectives while integrating diverse disciplines and sectors. Projects, funded for up to five years, must align with AHRC or NSF-SBE research themes and demonstrate a proportionate commitment from project leads.

Apply for AHRC standard research grant funding to support collaborative arts and humanities projects. Projects must involve a UK-based project lead and at least one co-lead to develop and manage the research. These grants aim to foster collaborations within and beyond academia, enhance career development for researchers, and promote effective dissemination of research outcomes. Proposals can involve interdisciplinary or international partnerships and may include individual research components that demonstrably add value to the overall project.

The LSIMF will provide capital grants across the UK and sector-wide to support investments in the manufacturing of human medicines (including active pharmaceutical ingredients and finished products), medical diagnostics (for disease identification and monitoring), and MedTech products (medical devices for human health). The fund will remain open until all funding is allocated.

The Space4Rail initiative, led by the European Space Agency (ESA), aims to enhance the railway sector by integrating space-based assets—such as satellite navigation, satellite communications, and Earth observation—into innovative and sustainable applications and services. The goal is to improve the performance, efficiency, safety, and attractiveness of railways for both operators and end-users. ​

‍

The NIHR Invention for Innovation (i4i) Programme funds collaborative R&D projects for medical devices, in vitro diagnostics, and digital health technologies that address unmet health or social care needs, have at least proof-of-concept (TRL 3), and show a clear route to NHS or social care adoption and commercialisation. The focus is on de-risking innovations through preclinical/clinical development and real-world evaluation, with eligibility open to UK-based HEIs, SMEs, NHS or social care providers, and not-for-profits.

Breakthrough 6 invites innovative ideas from appointed water companies in England and Wales to tackle major water sector challenges and deliver benefits for customers, communities, and the environment. Entries should request £150,000–£2 million in funding, with partners contributing at least 10% financially. Collaboration is strongly encouraged, particularly with SMEs and other sector organisations. Projects can run for less than a year or extend beyond 2031, with successful applicants notified by April 2026 following eligibility checks and panel review.

‍

This competition funds business-led collaborative research and development projects focused on industrial research between the UK, Japan, and other Eureka participating countries, with Innovate UK supporting the UK partners only. Projects must demonstrate strong market potential and aim to develop innovative products, technology-based applications, or services that involve technological risk and represent a substantial advancement beyond incremental improvements. Funding will not be provided for projects involving non-civilian technologies, work in the nuclear or drug discovery sectors, or those lacking at least one UK-registered business and one eligible Japanese partner.

We are interested in funding high quality applied health and social care research to increase and improve the evidence base about early action and prevention with health and social care services. Innovation that could facilitate a marked change in how we deal with complex health issues.

We are looking to fund research which has the potential to inform prevention services at a national level, and therefore local or regional evaluations are unlikely to be fundable. Similarly, evaluations focused on emerging technologies will require evidence of readiness for research on large-scale service delivery, including the published evidence base. All research should consider health and/or social care inequalities, or research focusing on how reducing inequalities can be integrated into prevention services. Alongside this, increasing access to neighbourhood health and social care services, moving care from hospitals into the community, and/or avoiding hospital admissions in the context of prevention are of particular interest to HSDR.

‍

The NIHR Decarbonising the Health and Social Care System fund supports UK research that reduces carbon emissions and promotes sustainability in health and social care. With £25 million available over five years, it backs projects developing or evaluating innovations, service models, or care pathways that advance net zero goals and can inform policy and practice. Open to UK-based researchers and organisations, the programme encourages collaboration with SMEs, charities, and local authorities to deliver practical, scalable solutions.

‍

This funding opportunity supports high-quality applied health and social care research focused on early action, prevention, and reducing inequalities at a national level. It aims to generate evidence that improves prevention services, enhances access to community-based care, and reduces hospital admissions. Research should address preventative strategies, early diagnosis, and interventions for those at risk of long-term conditions, demonstrating clear national impact and relevance to the NHS and social care. Areas of interest include improving prevention pathways, integrating preventative approaches, using data to deliver proactive support, and evaluating innovative service models or technologies. There are no specific eligibility restrictions for applicants.

‍